Luyan Pharma Co Ltd (002788) - Total Liabilities

Latest as of March 2026: CN¥9.95 Billion CNY ≈ $1.46 Billion USD

Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has total liabilities worth CN¥9.95 Billion CNY (≈ $1.46 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Luyan Pharma Co Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Luyan Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 002788 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Luyan Pharma Co Ltd Competitors by Total Liabilities

The table below lists competitors of Luyan Pharma Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Ricegrowers Ltd
AU:SGLLV
Australia AU$646.47 Million
Kocaer Celik Sanayi ve Ticaret A.S.
IS:KCAER
Turkey TL11.75 Billion
Assystem S.A.
PA:ASY
France €342.40 Million
Pony Testing International Group Co
SHE:300887
China CN¥513.12 Million
CytomX Therapeutics Inc
NASDAQ:CTMX
USA $39.41 Million
Chengdu Huaqi Houpu Holding Co Ltd
SHE:300471
China CN¥1.12 Billion
Contec Medical Systems Co Ltd
SHE:300869
China CN¥1.02 Billion
Markor International Home Furnishings Co Ltd
SHG:600337
China CN¥4.44 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Luyan Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Luyan Pharma Co Ltd (002788) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.11 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.95 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.75 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Luyan Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Luyan Pharma Co Ltd (2011–2025)

The table below shows the annual total liabilities of Luyan Pharma Co Ltd from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥10.07 Billion
≈ $1.47 Billion
+6.62%
2024-12-31 CN¥9.45 Billion
≈ $1.38 Billion
+7.15%
2023-12-31 CN¥8.82 Billion
≈ $1.29 Billion
-1.96%
2022-12-31 CN¥8.99 Billion
≈ $1.32 Billion
+21.00%
2021-12-31 CN¥7.43 Billion
≈ $1.09 Billion
+23.29%
2020-12-31 CN¥6.03 Billion
≈ $882.18 Million
+6.70%
2019-12-31 CN¥5.65 Billion
≈ $826.77 Million
+27.92%
2018-12-31 CN¥4.42 Billion
≈ $646.34 Million
+23.86%
2017-12-31 CN¥3.57 Billion
≈ $521.83 Million
+67.16%
2016-12-31 CN¥2.13 Billion
≈ $312.17 Million
-20.49%
2015-12-31 CN¥2.68 Billion
≈ $392.61 Million
+0.69%
2014-12-31 CN¥2.66 Billion
≈ $389.93 Million
+17.50%
2013-12-31 CN¥2.27 Billion
≈ $331.85 Million
+27.67%
2012-12-31 CN¥1.78 Billion
≈ $259.93 Million
+82.53%
2011-12-31 CN¥973.17 Million
≈ $142.40 Million
--

About Luyan Pharma Co Ltd

SHE:002788 China Pharmaceutical Retailers
Market Cap
$637.88 Million
CN¥4.36 Billion CNY
Market Cap Rank
#11212 Global
#3197 in China
Share Price
CN¥11.22
Change (1 day)
-0.71%
52-Week Range
CN¥7.99 - CN¥27.49
All Time High
CN¥22328.40
About

Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian… Read more